Terbinafine Patent Expiration
Terbinafine was first introduced by Karo Healthcare Inc
Terbinafine Patents
Given below is the list of patents protecting Terbinafine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lamisil |
US5681849 (Pediatric) | Pharmaceutical composition for topical applications |
Apr 28, 2015
(Expired) | Karo Hlthcare |
| Lamisil At |
US5681849 (Pediatric) | Pharmaceutical composition for topical applications |
Apr 28, 2015
(Expired) | Karo Hlthcare |
| Lamisil | US5681849 | Pharmaceutical composition for topical applications |
Oct 28, 2014
(Expired) | Karo Hlthcare |
| Lamisil At | US5681849 | Pharmaceutical composition for topical applications |
Oct 28, 2014
(Expired) | Karo Hlthcare |
| Lamisil |
US5856355 (Pediatric) | Pharmaceutical composition |
Nov 18, 2012
(Expired) | Karo Hlthcare |
| Lamisil |
US6005001 (Pediatric) | Pharmaceutical composition |
Nov 18, 2012
(Expired) | Karo Hlthcare |
| Lamisil At |
US5856355 (Pediatric) | Pharmaceutical composition |
Nov 18, 2012
(Expired) | Karo Hlthcare |
Terbinafine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List